Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

S Hummel

Showing results (121-130 of 123) with videos related to

Pageof 13
Sort By:
You have reached the last page of results.This site can display upto 123 results.
Assay and Drug Development Technologies|October 2, 2015
A High-Throughput Genetic Complementation Assay in Yeast Cells Identified Selective Inhibitors of Sphingosine Kinase 1 Not Found Using a Cell-Free Enzyme AssayMohammed A Kashem, Charles A Kennedy, Kylie E Fogarty, et al.
ESC Heart Failure|December 8, 2021
Resting and exercise haemodynamic characteristics of patients with advanced heart failure and preserved ejection fractionT Deis, E Wolsk, J Mujkanovic, et al.
Allergy|August 29, 1998
Tree-pollen allergy is efficiently treated by short-term immunotherapy (STI) with seven preseasonal injections of molecular standardized allergensB R Balda, H Wolf, C Baumgarten, et al.
Pageof 13

Showing results (121-130 of 123) with videos related to

Sort By:
Pageof 13
You have reached the last page of results.This site can display upto 123 results.
Assay and Drug Development Technologies|October 2, 2015
A High-Throughput Genetic Complementation Assay in Yeast Cells Identified Selective Inhibitors of Sphingosine Kinase 1 Not Found Using a Cell-Free Enzyme AssayMohammed A Kashem, Charles A Kennedy, Kylie E Fogarty, et al.
ESC Heart Failure|December 8, 2021
Resting and exercise haemodynamic characteristics of patients with advanced heart failure and preserved ejection fractionT Deis, E Wolsk, J Mujkanovic, et al.
Allergy|August 29, 1998
Tree-pollen allergy is efficiently treated by short-term immunotherapy (STI) with seven preseasonal injections of molecular standardized allergensB R Balda, H Wolf, C Baumgarten, et al.
Pageof 13